Role of PARP and TRPM2 in VEGF Inhibitor‐Induced Vascular Dysfunction
Karla B Neves(University of Glasgow), Rhian M. Touyz(University of Ottawa)
Cited by 17
Related Papers
c-Src–Dependent Nongenomic Signaling Responses to Aldosterone Are Increased in Vascular Myocytes From Spontaneously Hypertensive Rats
|Hypertension|2005|104
ER stress and Rho kinase activation underlie the vasculopathy of CADASIL
|JCI Insight|2019|49
Vascular dysfunction in obese diabetic db/db mice involves the interplay between aldosterone/mineralocorticoid receptor and Rho kinase signaling
|Scientific Reports|2018|44
Microparticles from vascular endothelial growth factor pathway inhibitor-treated cancer patients mediate endothelial cell injury
|Cardiovascular Research|2019|44